ArticleJournal of cancer research and clinical oncology2014

Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.

Verena Kirn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.